Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease

NCT02752191 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Congenital Heart Disease

Interventions

DRUG: ferumoxytol
DRUG: gadofosveset

Sponsor

Paul Finn